key: cord-0309399-ytc5xgvo
authors: Segal, A.; Parkes, L.; Aquino, K.; Kia, S. M.; Wolfers, T.; Franke, B.; Hoogman, M.; Beckmann, C. F.; Westlye, L. T.; Andreassen, O. A.; Zalesky, A.; Harrison, B. J.; Davey, C.; Soriano-Mas, C.; Cardoner, N.; Tiego, J.; Yücel, M.; Braganza, L.; Suo, C.; Berk, M.; Cotton, S.; Bellgrove, M. A.; Marquand, A. F.; Fornito, A.
title: Regional, circuit, and network heterogeneity of brain abnormalities in psychiatric disorders
date: 2022-03-10
journal: nan
DOI: 10.1101/2022.03.07.22271986
sha: b283745680b80683a7abafc379f3e99cadbcf4e4
doc_id: 309399
cord_uid: ytc5xgvo

The substantial individual heterogeneity that characterizes mental illness is often ignored by classical case-control designs that rely on group mean comparisons. Here, we present a comprehensive, multiscale characterization of individual heterogeneity of brain changes in 1294 cases diagnosed with one of six conditions and 1465 matched healthy controls. Normative models identified that person-specific deviations from population expectations for regional grey matter volume were highly heterogeneous, affecting the same area in <7% of people with the same diagnosis. However, these deviations were embedded within common functional circuits and networks in up to 56% of cases. The salience/ventral attention system was implicated transdiagnostically, with other systems selectively involved in depression, bipolar disorder, schizophrenia, and ADHD. Our findings indicate that while phenotypic differences between cases assigned the same diagnosis may arise from heterogeneity in the location of regional deviations, phenotypic similarities are attributable to dysfunction of common functional circuits and networks.

The neurobiological mechanisms of mental illness are elusive. Thousands of neuroimaging studies have documented a diverse array of structural and functional brain changes associated with specific psychiatric diagnoses and meta-analyses of this work have identified the brain regions that are most consistently affected in each condition, revealing both diagnosis-specific and transdiagnostic effects 1, 2, [11] [12] [13] [14] [15] [3] [4] [5] [6] [7] [8] [9] [10] . However, despite this substantial research effort, pathophysiological processes are poorly understood, and clinically useful biomarkers are lacking.

One reason for this limited progress may be a continued reliance on case-control designs, which focus on comparison of group-mean values and ignore the considerable clinical heterogeneity often shown by individuals with the same diagnosis [16] [17] [18] [19] . Indeed, recent neuroimaging studies that investigate individual-specific patterns of brain deviations have found that group average differences are not likely to be representative of individual cases [20] [21] [22] [23] [24] [25] [26] . These individual-specific inferences are often performed using normative modelling 27 , which involves training a model to learn normative expectations for a brain phenotype, such as grey matter volume (GMV), given an individual's age, sex, or other relevant characteristics. The model predictions can then be used to define a normative range of variation against which new individuals are compared. Fitting the model to data for multiple brain regions allows one to obtain a personalized deviation map that quantifies the extent to which the individual deviates from population norms within each brain region, thus enabling the identification of brain regions associated with unusually small or large phenotypic values, termed extreme deviations, in an individual. Normative modelling studies of diverse MRI-derived phenotypes in attention-deficit/hyperactivity disorder 20 (ADHD), bipolar disorder (BP), schizophrenia 21, 24, 26 (SCZ), autism spectrum disorder 22, 23, 25 (ASD) have found that, while cases often have more extreme deviations than healthy controls, the specific location of these deviations varies considerably between individuals with the same diagnosis. This extreme regional heterogeneity of individual brain deviations aligns with the welldescribed clinical heterogeneity often associated with specific psychiatric diagnoses [16] [17] [18] [19] , but raises an important question: if cases show little overlap in the anatomical locations of their GMV deviations, what then explains phenotypic similarities between people assigned the same diagnostic label? It seems reasonable to assume that such similarities are driven by some common aspect of neural dysfunction across individuals, but the findings of normative modelling studies suggest otherwise.

One possible explanation is that while the specific location of brain deviations may vary across individuals, these deviations aggregate within common circuits or neural systems. The brain is a connected network, and pathological processes often affect distributed, interconnected systems 28-30 , meaning that it is possible for deviations in disparate loci to impact the function of common, connected areas. This principle has been demonstrated through lesion network mapping studies of neurological patients sharing a common motor, perceptual, or cognitive syndrome 31, 32 . Specifically, this work has shown that patients often show little overlap in the anatomical location of their lesions, but that lesioned sites are often functionally coupled to common areas 31, 33, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [34] [35] [36] [37] [38] [39] [40] [41] . The clinical expression of such syndromes thus appears to be more closely related to dysfunction of these coupled areas rather than of the lesioned region itself.

Here, we considered whether a similar process is at play in psychiatric disorders. Specifically, we investigated whether anatomically heterogeneous regional brain deviations within psychiatric disorders are functionally coupled to common areas and networks. To this end, we developed a new framework to integrate normative models of GMV with elements of lesion network mapping to map the functional circuits and extended networks within which regional GMV deviations are embedded.

We used this approach to derive a multiscale characterization of neural heterogeneity across 1294 individuals diagnosed with one of six disorders: ADHD, ASD, BP, major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and SCZ. Inspired by studies of patients with brain lesions 31,32 , we tested the hypothesis that anatomically heterogeneous regional GMV deviations in each disorder are functionally coupled with common sites, either within a functional circuit or an extended functional network (see Figure 1 for a schematic explanation). Our transdiagnostic, multiscale approach allowed us to comprehensively understand the extent of neural heterogeneity within each disorder while also revealing commonalities and differences between disorders. Nodes represent different brain regions, edges represent functional coupling between nodes, and colored areas correspond to different functional networks of the brain. At the regional level (left), deviations from normative model predictions are localized to specific brain regions in each individual. Red nodes show the locations of such deviations mapped in two different people. A circuit-level analysis (middle) reveals areas the areas that are functionally coupled to the deviant loci. In this work, we define a functional circuit as the set of regions that show significant functional coupling with a specific deviant region (orange). In this example, the two deviant areas are coupled to a common region (black arrow) despite being located in different areas themselves. (c) These circuits can be embedded within extended networks (right) that include regions which may not be directly coupled to the deviant regions, but which nonetheless participate within the same functional system (yellow). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ;  https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint

We examined data for 1465 healthy controls (HC; 54 Table S1 (for age distributions, see Figure S1 ).

We used an established pipeline to obtain voxel-wise estimates of GMV in each participant 52,53 (see Methods). Voxel-wise GMV estimates were converted into regional estimates for 1032 brain areas defined according to previously validated, functionally-constrained parcellations 54, 55 (1000 cortical regions, 32 subcortical regions; Figure 2a) . We then defined a training set comprising 1196 HCs (55.02% male ; Figure 2a ; HCtrain) to train, separately in each region, a normative model based on hierarchical Bayesian regression 56 (HBR), thus establishing a normative GMV range given an individual's age, sex, and scan site (Figure 2b ). HCtrain spanned the age range of cases, enabling predictions for ages between 18 and 64 years ( Figure S2 ). The remaining 269 controls (52.04% male; age range 18-62) were held-out as a test set (HCtest) to establish a normative benchmark for comparison with each clinical group (Figure 2c) . A detailed explanation of our modelling procedure is provided in the Methods. Model fit statistics and checks for residual site effects are provided in Figure   S3 and Table S2 .

For each individual in the clinical and HCtest groups, we quantified the degree to which regional GMV estimates deviated from normative model predictions as a z-score (termed Deviation zmaps; see Methods and Figure 2d ). Following Wolfers et al. 21 , a -score > |2.6| defined an extreme deviation (Figure 2e ), corresponding to < .005, uncorrected (see Methods for a discussion of thresholding issues). Figure S4 shows the distribution of positive and negative person-specific deviation burden scores (i.e., the total number of extreme deviations identified in a person) across individuals, stratified by diagnostic group. Nonparametric rank sum tests indicated that people with BP, MDD, OCD and SCZ showed a higher burden of extreme negative deviations compared to HCtest (p<0.003), indicating lower GMV than age-and sex-specific expectations. Only people with ASD showed a higher positive deviation burden than controls (p<0.001, descriptive statistics provided in Table S3 ). Critically, rank correlations indicated scan quality (as measured by CAT12's IQR) was not meaningfully associated with extreme deviation burden (HCtest: rho = 0.04, p=0.51; cases: rho = 0.03, p=0.34). In the following, we focus on a multiscale characterization of negative GMV deviations (i.e., is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint areas where volume is lower than normative expectations), as these have been most extensively studied in the psychiatric literature . Results for our analysis of positive GMV deviations can be found   in Figures S17-24 and Table S4 -5, and a discussion is in the Supplementary Material (Discussion of positive GMV deviations).

We characterized regional heterogeneity in GMV (Figure 1 left) by assessing the degree of spatial overlap in the location of each individual's extreme negative deviations (Z < -2.6, i.e., lower GMV than expected). Specifically, we quantified the proportion of individuals showing an extreme deviation in each parcellated brain area separately for each diagnostic group and the HCtest cohort ( Figure 2f ). Across all groups, the majority of individual showed at least on extreme deviation, ranging from 75.82% in ADHD to 88.51% in SCZ. Nonetheless, across all groups and all 1032 brain regions, the maximum percentage overlap never exceeded 7% (ADHD: 3.27%, ASD: 4.95%, BP: 5.26%, MDD: 6.21%, OCD: 4.19%, SCZ: 4.96% HC: 2.97%). Hence, while individual extreme deviations were common, they were rarely found in consistent locations across individuals with the same diagnosis ( Figure S5 ).

We next compared the degree of spatial overlap between each clinical group and controls by Figure 2h ). These differences were scattered throughout the cortex and rarely aggregated into spatially structured clusters. Few regions showed significantly greater overlap in controls compared to cases ( Figure S7 ). Repeating the analyses using a method that integrates across a range of thresholds rather than relying on a single threshold for defining extreme deviations 57 yielded similar findings (see Methods; Figure S8 -S10). Collectively, these results extend past findings 20, 21, 26 to indicate that minimal spatial overlap in the location of person-specific extreme GMV deviations is a general characteristic of psychiatric illness. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

We next asked whether the regionally heterogeneous extreme deviations identified in each clinical group show significant functional coupling (FC) with common, remote areas, thus yielding greater inter-individual consistency at the level of functionally coupled circuitry (Figure 1 , middle).

To this end, we took each region showing an extreme deviation in each participant ( Figure 3a ) and mapped its pattern of whole-brain FC in an independent sample of 150 unrelated healthy controls (HCP150) to establish the normative pattern of expected FC for the deviant region ( Figure 3b ). We thresholded ( !"# < 0.025) and binarized each deviant-related FC map (Figure 3c) , and took the union of these thresholded maps across all extreme deviations for a given person (Figure 3d ; for a discussion of thresholding issues, see Discussion), yielding a map that represents all areas showing significant FC with at least one extreme deviation in that individual. Next, we estimated, for each region, the proportion of individuals within each group for whom that region showed significant FC with an extreme deviation ( Figure 3e ). This analysis revealed that the overlap observed in sites functionally coupled to deviant regions was much higher, in absolute terms, than the overlap observed in the locations of the extreme deviations themselves ( Figure S11 ). For instance, the maximum circuit-level overlap observed across regions was 33% in the HCtest group and ranged between 39% (ADHD) and 53% (SCZ) in the clinical groups.

To a certain extent, one should expect overlap to be higher at the level of FC union maps (Figure 3d-e) than regional deviation maps (Figure 2e-f), since any given deviant area can show FC with multiple other regions, increasing the likelihood that common areas will be implicated across individuals. For this reason, regional circuit-level overlap maps in each clinical group must be contrasted with the HCtest overlap map, which provides a normative benchmark for the expected level of overlap in FC union values (Figure 3f) . A critical consideration in these contrasts concerns the effect of total deviation burden, which differs between groups (e.g., Figure S4 ). For instance, the total number of extreme deviations identified in individuals diagnosed with SCZ was 4951 compared to only 1410 in HCtest. This discrepancy means that more deviant-related FC maps will be used in the FC union maps of SCZ individuals, thereby increasing the chance of observing higher overlap across individuals. On the one hand, this higher circuit-level overlap will have real phenotypic consequences, since a higher deviation burden is an intrinsic and expected characteristic of psychiatric disorders and these deviations are likely to impact circuit-level function in a way that affects behavior. On the other hand, it is important to know whether the overlap is driven simply by group differences in deviation burden or reflects a preferential targeting of the circuit by the disorder in question. We therefore evaluated the statistical significance of regional group differences in circuit-level overlap using two different permutation tests designed to disentangle these effects (see Methods and Figure is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint regardless of group differences in total deviation burden, thereby characterizing group differences in their "natural" state. The second, spatial permutation test, evaluated group differences with respect to a null distribution that preserves the number of deviation-related FC maps contributed by each individual, thus matching differences in the total deviation burden of each group (see Methods and Figure S6e-k). This analysis therefore tests whether observed group differences in circuit-level overlap are greater than expected for FC maps generated from the same number of randomly chosen seeds, with the random seeds being selected from a deviation map with the same underlying spatial autocorrelation as the empirical deviation maps (see Methods for further details and interpretation).

Using the group-based permutation tests, we observed significantly greater overlap across wide swathes of cortex for both people with SCZ and MDD (pFDR < 0.05, two-tailed) compared to controls ( Figure 3g ). Regions with significantly greater overlap in SCZ were distributed diffusely and included ~75% of cortical areas. In MDD, ~31% of areas were implicated, being predominately localized to regions of visual, parietal, somatomotor, frontal, and insula cortices. A similar spatial pattern of findings was observed for people with ASD, OCD, and BP when considering uncorrected results, although fewer regions survived FDR correction. Very few areas showed greater overlap in deviant-related FC in controls compared to cases ( Figure S12a ). An alternative method for mapping FC results to parcellated regions yielded comparable findings (see Methods and Figures S13, S14a-15a). These findings support the hypothesis that GMV deviations in psychiatric disorders are part of common functional circuits despite being located in anatomically heterogeneous areas.

We next used the spatial permutation test to determine the degree to which the above differences in circuit-level overlap were attributable to deviation burden. The results, shown in Figure   3h , indicate that all disorders show some evidence for greater overlap in regions of left inferior and middle frontal gyri at uncorrected thresholds. However, only three areas in BD and one in MDD survived FDR correction. Similarly, few results survived FDR correction when considering regions showing greater overlap in controls ( Figure S12b ) and an alternative method for mapping FC results to our regional parcellation yielded comparable findings (see Methods, Figure S14b-15b). Thus, while these findings offer preliminary evidence for the preferential involvement of neural circuitry involving the lateral prefrontal cortex in each disorder, they indicate that the dominant factor explaining greater circuit-level overlap in cases is total deviation burden. In other words, cases show greater overlap at the circuit level largely because they are more likely to express extreme GMV deviations, which in turn increases the probability with which sites functionally coupled to deviant areas will be implicated. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. 

Our analysis thus far indicates that the loci of regional GMV deviations show marked individual heterogeneity, that cases show substantially greater overlap when considering the functional circuitry of these deviant loci, and that this overlap is largely driven by total deviation burden. However, our circuit-level analysis only focused on areas showing significant FC with deviant regions, and these circuits often form part of larger, extended functional networks that may Table S4 for a summary of the degree of spatial overlap (%) in each network for each group). Using group-based permutation testing, SCZ and MDD cases showed significantly greater overlap in multiple networks compared to controls (q < 0.05, two-tailed, Figure 4f is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint the medial temporal lobe and dorsal attention networks showed greater overlap in ADHD (Figure 4g ).

No deviant-related networks showed greater overlap in controls ( Figure S16b ).

Together, these results align with the circuit-level analysis to indicate that SCZ and MDD are associated with greater network-level overlap in GMV deviations. The effects are more circumscribed in ADHD, ASD, BP, and OCD, although the salience/ventral attention network is implicated across most disorders. These effects are largely driven by total deviation burden, with only SCZ and ADHD showing robust evidence for preferential involvement of the salience/ventral attention and dorsal attention/medial temporal systems, respectively.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint clinical group, we assigned each brain region showing an extreme deviation to one of 10 canonical cortical functional networks or 3 subcortical nuclei (b), such that the entire network was considered deviant if it contained at least one region with an extreme deviation. Panel (c) shows the resulting network-level extreme deviation maps. (d) We quantified the proportion of individuals in each group showing a deviation within each network and compared these proportions to the network overlap in HCtest. (e) Group differences in networklevel overlap were evaluated with respect to two empirical null models (see Figure S6 for details). Panels (f) and (g) show the network-level -log10 p-values associated with the difference in percent overlap for extreme negative GMV deviations between each clinical group and the HCtest cohort (grey). ** corresponds to pFDR < 0.05, two-tailed, cases>controls, * corresponds to puncorrected < 0.05, two-tailed, cases>controls. The solid black line indicates -log10 p = 1.6 (p=0.05, two-tailed, uncorrected). Panels (f) and (g) identify networks showing significant differences under group-based or spatial permutation testing, respectively.

We used normative modelling to characterize the heterogeneity of extreme GMV deviations at the level of brain regions, functional circuits, and extended networks in six psychiatric disorders. We showed that heterogeneity between individuals in regional GMV abnormalities is a general feature of psychiatric illness, with relatively few areas showing significantly greater overlap in cases compared to controls and no single area in any disorder showing an extreme deviation in more than 7% of cases across the 1032 regions. However, these heterogeneous loci were often embedded within common functional circuits and networks, typically involving regions of lateral frontal, parietal, and insula cortex. In some cases, >50% of cases with the same diagnosis showed a deviation implicating at least one of these systems. Much of this elevated circuit and network level overlap across individuals was attributable to group differences in total deviation burden rather than the preferential targeting of a specific circuit or network, although we found evidence for selective involvement of prefrontal circuitry in MDD and BD, the salience/ventral attention network in SCZ, and the dorsal attention and medial temporal networks in ADHD. Together, our findings identify a putative neural substrate for both phenotypic differences and similarities between cases with the same diagnosis, with phenotypic differences being attributable to regional heterogeneity in the location of person-specific GMV deviations and phenotypic similarities attributable to the impact of these deviations on common functional circuits and networks.

The high degree of regional heterogeneity in GMV deviations across disorders aligns with past normative modelling studies of GMV in SCZ, ADHD, and BP 20,21,26 . The variable involvement of different regions across individuals may yield distinct clinical phenotypes and therefore drive phenotypic heterogeneity in people with the same diagnosis 16, 17, 59 . An important avenue of future work will involve precisely characterizing the relationship between GMV deviations and interindividual differences in symptom expression. More generally, the high degree of regional heterogeneity that we observe indicates that group-mean comparisons may not be representative of the specific profile of brain changes apparent in any individual case and may offer an incomplete is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint account of causal pathophysiological mechanisms unless the broader network context in which the differences occur is considered. Multiple mechanisms may explain these circuit-and network-level effects, ranging from transient diaschisis-like effects on distributed circuit/network function through to more prolonged transneuronal degeneration caused by aberrant inter-regional signaling or axonal transport of trophic factors 29 . Identifying the specific causal mechanisms at play in each disorder will be essential for understanding how pathophysiology spreads through connected neural systems in each disorder.

Despite considerable heterogeneity at the regional level, deviations were often coupled to common functional circuits and networks. This higher overlap at circuit and network levels parallels lesion network mapping studies of neurological syndromes, which suggest that many clinical phenotypes are not caused by dysfunction of the lesioned area itself but by its impact on functionally coupled remote areas 32 . Our findings indicate that a similar process may occur in psychiatric disorders, such that anatomically distributed GMV deviations are often coupled within similar circuits and networks, and the consequent dysfunction of these common circuits and networks may drive clinical similarities between people with the same diagnostic label despite extreme heterogeneity in the locations of the deviations themselves. Indeed, our group-based permutation testing indicated that all disorders show some evidence of greater circuit-level overlap than controls. Areas of frontal, parietal, insula, and temporal cortex were implicated across most conditions, and cross-disorder differences were more of degree rather than kind. For instance, differences in circuit-level overlap were spatially circumscribed in ADHD but encompassed nearly the entire brain in SCZ ( Figure 3 ).

These findings challenge classical views that specific psychiatric disorders are associated with dysfunction in distinct circuits (e.g., 60 ) and align with evidence that each disorder is associated with complex changes that affect diverse neural systems, often transdiagnostically 61, 62 . Accordingly, our network-level analysis revealed greater overlap in the salience/ventral attention network in 5 of the 6 disorders that we considered ( Figure 4 ). The salience/ventral attention network plays a central role in cognitive control 63 , interoceptive awareness 64 , and switching between internally and externallyfocused attention 65 . Its dysfunction has been implicated in a diverse range of psychiatric disorders 66-69 , is associated with increased levels of general psychopathology in youth 70 , and shows cross-disorder abnormalities in meta-analyses of classical case-control VBM studies and functional neuroimaging studies 9,71 . Our findings support this past work to suggest that salience/ventral attention network dysfunction may play a critical role in the expression of general psychopathological processes common to diverse diagnoses 72 .

Our spatial permutation test allowed us to evaluate the degree to which circuit and network- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 79, 80 and in association to disorder-related cognitive control deficits using task-based fMRI studies 73 . Moreover, dorsolateral PFC is typically used as a transcranial magnetic stimulation (TMS) target site to treat depressive symptoms in MDD 81 and BP 82 and has been implicated by lesion network mapping as a core site explaining the emergence of depression following stroke 47 . Given that our spatial permutation test did not find any evidence for greater network-level overlap in MDD and BD, our findings point to a strong specificity for circuits coupled to these particular prefrontal areas.

Spatial permutation testing also revealed greater network-level overlap for SCZ in the salience/ventral attention network and for ADHD in the dorsal attention network and medial temporal regions. GMV deviations may thus preferentially aggregate within these systems in a disorder-specific way.

In most other cases, we failed to reject the spatial null hypothesis. This result suggests that many case-control differences in circuit/network overlap observed under group-based permutation cannot be attributed to the preferential accumulation of deviations in a particular circuit/network, since the differences are consistent with expectations from comparing the same number of randomly selected seeds in each group. A corollary of this finding is that many GMV deviations in individual cases may emerge at random locations throughout the brain. As these deviations accumulate, they are more likely to be coupled to areas in prefrontal, temporal, parietal and insula cortices, simply because these areas, which are known as connectivity hubs of the brain 83,84 , have a higher probability of being functionally coupled to other regions. Further work investigating the genetic and environmental contributions to individual-specific deviations should help to better understand the causal mechanisms driving their anatomical distribution.

Sample sizes in single site psychiatric neuroimaging studies are often small, so we pooled data from multiple sites to generate a sufficiently large cross-disorder dataset. As a result, the data were collected with different acquisition, recruitment, and clinical assessment protocols. Although we used stringent quality control, and our hierarchical Bayesian model 56 was able to appropriately parse site-related variance (Table S2) , investigating correlations with symptom profiles or other clinicallyrelevant variables such as age of onset, illness duration, medication exposure, or disease severity across disorders was beyond our scope. Furthermore, this study focused on adult neuroimaging data, and the nature and magnitude of case-control differences may vary as a function of age 12 . In future studies, harmonized multisite clinical protocols across different disorders, such as those informed by the Hierarchical Taxonomy of Psychopathology 85 , collected across the lifespan, could be used to investigate these effects in more detail.

Our cases were diagnosed according to DSM criteria 86 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint respect to these constructs and to gain insight into the neural correlates of phenotypic similarities and differences between cases assigned specific diagnoses. Nonetheless, focusing on specific syndromes rather than traditional diagnoses, as in the lesion network mapping literature 32 , may yield a more precise mapping between regional deviations, their network context, and behavior. Establishing sufficiently large databases for conducting such syndrome-focused analyses will be a key challenge for future work.

One factor complicating comparisons between regional, circuit, and network-level analyses is that the pipelines used for mapping deviation overlap rely on different thresholds. For instance, regional deviations are defined at z>|2.6|, whereas circuit-level results additionally rely on the threshold used to define the FC of deviant regions and the vertex-to-parcel mapping threshold (see Methods). In our analyses, we used a standard whole-brain corrected threshold for mapping the FC of deviant brain regions, so our results in this context align with typical expectations of the field. We also demonstrated that our findings were consistent across reasonable vertex-to-parcel mapping thresholds of 50% and 75%, suggesting a relative insensitivity to this parameter (see Figures 3, . We also obtained similar results for the regional analysis when using an approach that integrates across a range of thresholds for defining extreme deviations that does not rely on a single fixed threshold value (See Methods, Figures S8-10 ).

In conclusion, our multiscale analysis of neural heterogeneity across six psychiatric disorders confirms that extreme regional heterogeneity of GMV deviations is a general characteristic of mental illness. Further, we showed that these deviations are often coupled to common functional circuits and networks, offering a putative neural substrate for phenotypic similarities between individuals assigned the same diagnosis. Similarly, the common involvement of prefrontal and parietal circuits, and the salience/ventral attention network, across disorders may be a marker of transdiagnostic psychological distress, with the variable involvement of other systems explaining phenotypic differences between disorders. As has been extensively documented in neurological syndromes 32 , our findings underscore the need to consider the network context of disorder-related pathophysiology 29 and indicate that the clinical expression of disease is not driven solely by sites of primary pathology, but also by the effect of this pathology on remote, connected systems.

The study was approved by the local ethics committee of each dataset, and written informed consent was obtained from each participant. This study was approved by the Monash University Research Ethics Committee (Project ID: 23534).

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Full details on study design and clinical characteristics have been described previously for each dataset (see Table S1 for basic characteristics and relevant references). Each study was approved by the relevant ethics committee and written informed consent was obtained from each participant.

The final sample that we examined was taken from a larger pool of individuals recruited across the 14 datasets. In addition to the specific quality control procedures used within each study (references in Table 1 ), we performed a series of additional quality control checks and exclusions for our analysis. Specifically, we excluded participants if they were below 18 years or above 64 years of age (N=346); did not have the necessary clinical data (clinical diagnosis or, for healthy controls, absence of any clinical diagnosis) or demographic information (age, sex and scanner site, N=53); if their T1-weighted structural magnetic resonance imaging (MRI) scan did not survive our stringent manual and automated quality control procedure, as explained below (N=269); or if the data came from a site with less than 10 individuals in the same group and sex (described in the Normative model section, below; N=217). Our final sample available for analysis thus comprised 1465 HCs and 1294 cases. Demographic and other details of this cohort are presented in Table S1 .

Our analysis aimed to characterize neural heterogeneity at the level of individual brain regions, neural circuits, and extended brain networks (Figure 1 ). To map heterogeneity at the regional level, we obtained person-specific deviation maps, representing the extent to which the grey matter volume (GMV) of a given person within each brain region deviates from normative predictions. This analysis involved quantifying regional GMV for each individual and evaluating the observed measures with respect to an underlying normative model, as outlined in the following.

We estimated regional GMV using voxel-based morphometry 87 (VBM) of T1-weighted anatomical MRI scans 52, 87 . We focused on GMV because it is one of the most frequently studied neural phenotypes in psychiatry. VBM is also arguably the most widely used tool for measuring GMV in this context. Image acquisition parameters for each dataset are provided in Table S1 . The following outlines our quality assurance procedures and data processing pipeline, which was applied to all raw T1-weighted images obtained for each dataset.

All T1-weighted images were visually inspected and evaluated for the presence of artifacts 88, 89 , resulting in the exclusion of 53 images with gross artifacts or abnormalities. Next, we is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint used the Computational Anatomy Toolbox 52 (CAT12 r113, http://dbm.neuro.uni-jena.de/cat/) to generate a weighted overall image quality rating (IQR) for every scan. This metric combines ratings of basic image properties, including the level of noise and geometric distortions, into a single score that quantifies the overall image quality of a participant's T1-weighted scan (see here for more information www.neuro.uni-jena.de/cat/index.html#QA ). On this metric, lower scores denote higher image quality. As per previous work 21 , we excluded 153 images with an IQR > 2.8. An additional 63 images were excluded due to a failure of our processing pipeline. Collectively, this quality assurance process resulted in the exclusion of a total of 269 scans.

Regional GMV was estimated using the CAT12 VBM pipeline, which is included as an To constrain our analyses to GM voxels, we generated a mean image from all the normalized GM maps and retained voxels with a tissue probability³0.2.

We employed hierarchical Bayesian regression (HBR) to estimate normative models of regional GMV (see Normative Model section, below). To limit computational burden, we parcellated the brain into 1032 cortical and subcortical regions by combining well-validated parcellations of the cortex 54 comprising, 1000 regions, and of the subcortex 55 , comprising 32 regions. The cortical parcels have been mapped to well-described, canonical functional networks of the brain 58 , facilitating our analysis of network-level overlap in deviations. Voxels that overlapped between atlases were assigned to the corresponding subcortical region. Regional GMV estimates were obtained using freely available code (http://www0.cs.ucl.ac.uk/staff/gridgway/vbm/get_totals.m).

Note that the choice of parcellation will necessarily affect the magnitude of overlap that can be observed in any given brain area, such that coarser parcellations will be associated with higher levels of overlap. Comparison to the control data thus provides a critical normative benchmark against which to evaluate the levels of overlap observed in each clinical group. We chose our 1032-region parcellation to offer as much spatial resolution as possible while still ensuring that our analyses were is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint computationally feasible. The same parcellation was used in regional, circuit, and network-level analyses, facilitating direct comparison across scales.

We used normative modeling to obtain person-specific GMV deviation maps in relation to an underlying model of normative expectations for regional GMV variations (see 27 for details; code available at https://github.com/amarquand/PCNtoolkit, version=0.16). Normative models estimate the mean and variance (referred to as a normative range) of a response variable (e.g., GMV) from a set of clinically relevant covariates (e.g., age and sex) across a large healthy sample, referred to as a training set. These estimates are then used to quantify the deviations of samples in the test subset, which typically consists of cases, from the normative range.

When using multi-site data, scanner-and site-related variability introduce artefactual variance that confounds the result of any subsequent analyses 91 . These confounding effects present as site-correlated biases that cannot be explained by biological heterogeneity between samples. To account for these site-related effects, we built our normative model using hierarchical Bayesian regression (HBR), which successfully accommodates signal and noise variance in multisite data by estimating different but connected mean and variance components through shared prior distributions across sites 56 . Prior to modelling, regional GMV estimates were first subjected to a Box-Cox transformation to ensure normality 92 . The optimal lambda parameter for minimizing skewness was estimated for each brain region independently using maximum likelihood.

For the model to accurately parse variance attributable to age, sex, and site, a sufficient number of observations is required for any given combination of these variables. We therefore excluded data cells containing less than 10 HCs for a particular sex at a given site. If this entire exclusion procedure resulted in less than 10 cases in total from any given site, the entire site was excluded, resulting in the exclusion of 217 scans.

The training data for the normative model (HCtrain) was created by randomly selecting 90% of HC individuals from each site, provided that the site included data for ³30 HCs. For sites with smaller HC samples, all HC data were included in the training set. The test data (HCtest), which was completely independent of the normative model, comprised the 10% of HCs from sites with ³30 HCs and all case scans. The HCtest data, comprising 269 individuals (140 male), offered a normative benchmark for assessing case-specific model deviations, as outlined below.

Following stratification of our sample into training and test subsets, for each brain region, we fitted separate HBRs 56 , modeling site and sex effects with random slopes, intercepts, and noise, to each of our 1032 parcellated brain regions to model GM volume as a function of age, sex, and site in the training data, yielding estimates of normative regional GMV variance and predictive uncertainty.

Importantly, based on a partial-pooling approach, shared prior distributions were imposed over site- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint specific and sex-specific model parameters. These shared priors assume that while the model parameters for each site and sex are different, they are drawn from a common distribution. These shared priors thus regularize the model parameters and prevent the model from overfitting small batches for a given sex or site.

To quantify deviations from the normative model predictions for each subject in the test data, we generated deviation z-maps for each individual. Specifically, for each subject, , at each brain region, , we combined the predicted GM volume, ,--, true GM volume, ./ , the predictive uncertainty, ./ , and the normative variance, %/ , to calculate a z-score, ./ , as

, which quantifies the extent to which an individual's regional GMV estimate deviates from the model prediction, given the uncertainty of the model. 

To assess model generalizability, we used 5-fold cross-validation (CV) applied to the HCtrain cohort (n = 1196 HC individuals, 55% male). Specifically, we split this group into 5 folds. Within each fold, we estimated an HBR model on 80% of participants, using age, sex, and site as covariates, to predict regional GMV in the remaining 20% of people. This procedure was repeated 5 times so that regional GMV values for all participants in the HCtrain group were predicted once. As above, we estimated deviation z-maps for every individual and identified extreme deviations.

For each fold in the CV, we assessed model fit for each brain region by evaluating three performance metrics: (i) explained variance (EXPV); (ii) the mean standardized log-loss (MSLL); and

(iii) the standardized mean-squared error (SMSE) 56 , as shown in Figure S3 . We also evaluated the model's efficacy in partitioning site-related variance in the data using linear support vector machines (SVM). Specifically, we used a series of one-versus-all linear support vector machines (LSVM with . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint default slack parameter = 1) trained separately on the z-maps from the HCtrain and the HCtest subsets to classify scan sites. For each site, we ran a 2-fold SVM classifier to obtain the mean balanced accuracy score for the given site. Here, a balanced accuracy at chance-level (50%) indicated that the resulting deviations were not contaminated by residual site effects, as confirmed in Table S2 . To assess whether individual variations in scan quality affected the deviation z-maps, we calculated the Pearson's correlation between the total number of extrema and CAT12's IQR rating in each group.

We characterized the heterogeneity of case-specific thresholded deviation maps for each disorder using a non-parametric approach. Specifically, for each clinical group and the HCtest cohort, we computed the proportion of individuals in each group showing an extreme deviation within each region, resulting in group-specific overlap maps estimated separately for positive and negative extrema (Figure 2f) . We used the proportion of individuals rather than raw counts to account for sample size differences between groups. Next, we subtracted the HCtest overlap map from each disorder's overlap map, resulting in an overlap difference map for each disorder (Figure 2g ). We then permuted group labels (i.e.,HC, case) and repeated the procedure 10,000 times to derive an empirical distribution of overlap difference maps under the null hypothesis of random group assignment ( Figure   S6a -c). For each brain region, we obtained p-values as the proportion of null values that exceeded the observed difference ( Figure S6d ). The tails of the null distribution (i.e., values associated with p< 0.10) were approximated using a generalized Pareto distribution 95 , as implemented in the Permutation Analysis of Linear Models software package 96 (PALM alpha116), to allow inference at arbitrarily high levels of precision. Statistically significant effects were identified using an FDR-corrected 94 threshold of pFDR<.05, two-tailed.

The procedure to characterize the regional heterogeneity of extreme deviations above used an arbitrary threshold (Z< |2.6|) on each individual z-map. The practical benefit of this approach is that it allows calculation of intuitive metrics, such as the proportion of cases within a group showing a supra-threshold deviation within a given brain region. We complemented this analysis with an alternative approach, which does not yield similarly intuitive metrics but which integrates results across a range of thresholds 57 , thus allowing us to determine the degree to which our findings depend on a specific threshold choice. First, for each diagnostic group, we thresholded z-maps across the threshold range 1.64 < Z < 3.10, in 100 equal log-space increments, separately for positive and negative extrema. Second, we obtained a region-and threshold-specific percentage overlap map quantifying the proportion of individuals within each group showing an extreme deviation for any given region and threshold. Third, we applied a weighted function to penalize less conservative thresholds. Fourth, we obtained a final threshold-weighted overlap map by taking the area under the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint curve of the cumulative histogram of the proportion of participants at each threshold for each region across participants. We used the following linear weighted function proposed by Seghier and Price 57 , which ensures that overlap map values range between 0 and 1, with 1 indicating an effect in a region is present in each subject at each threshold:

where 234 and 2.% respectively correspond to the maximum and minimum z-value thresholds, and ℎ is the given statistical threshold. We then calculated the difference between the thresholdweighted percentage overlaps between cases and the held-out HC cohort, resulting in an overlap difference map for each disorder. We performed inference on these differences using the same groupbased permutation procedure described above with statistically significance defined using a threshold of pFDR<.05, two tailed.

Having investigated neural heterogeneity at the level of individual brain regions, we next evaluated whether regions showing extreme deviations in individual cases are functionally coupled to common areas, which we term circuit-level heterogeneity (Figure 1 middle) . We define the functional circuitry of a brain region showing an extreme deviation as the set of brain areas that show significant FC with that region in an independent cohort of healthy individuals. To map this circuitry, we adapted elements of the lesion network mapping methodology used extensively in neurological disorders 31, 32 for use with normative modelling, as outlined in the following.

The functional circuitry of deviant regions was mapped using an independent cohort of 150 resting-state functional MRI (rs-fMRI) scans (71 males, age 21-35 years) from the S900 release of the Human Connectome Project 97 (HCP). These individuals corresponded to the 150 people with the lowest total head motion, as estimated using framewise displacement 98 , from the broader set of 282 unrelated participants with the same fMRI reconstruction in the S900 release. We focused on this subsample to minimize the effects of head motion in our FC maps and to minimize computational burden due to the large number of analyses required. Mapping deviation-related functional circuity in an independent cohort is essential because we seek to understand the circuit context of deviant regions under normative conditions. Our approach aligns precisely with the logic used in lesion network mapping of neurological patients 31, 32 .

The rs-fMRI data for each subject consists of four runs (rfMRI_REST1_LR, rfMRI_REST1_RL, rfMRI_REST2_LR, rfMRI_REST2_RL) acquired at two different sessions (REST1 and REST2) using two different directions of phase coding (LR: left to right, and RL: right to left). Here, we mapped deviation-related FC using the rfMRI_REST1_LR data. All rs-fMRI data were . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint obtained using a 32-channel Siemens 3T connectome-Skyra scanner. The imaging parameters for rs-fMRI were as follows: repetition time (TR) = 720 ms, echo time (TE) = 33.1 ms, flip angle (FA) = 52°, field of view (FOV) = 208 × 180 mm 2 , matrix = 104 × 90, slice number = 72, slice thickness = 2 mm, voxel size = 2 × 2 × 2 mm 3 , multiband factor = 8, and 1200 volumes. Participants were required to stay awake, relaxed, and to keep their eyes open and fixed on a bright cross-hair projected on a dark background. A detailed description of the HCP data is available in previous work 97 .

The rs-fMRI data used underwent the HCP's minimal pre-processing pipeline 99 , which includes gradient-nonlinearity-induced distortion, motion correction to the single-band reference image using FLIRT, EPI image distortion correction using TOPUP 100 , registration into standard space using a customized boundary-based-registration (BBR) algorithm, and single step spline interpolation using all transforms, intensity normalization and bias field removal to resample the original EPI into MNI space. Minimal high pass filtering was applied with a cutoff of 2000ms. Artifacts were then removed using ICA-FIX 101 . This involves employing an automatic classifier, specifically trained for HCP data, to identify ICA components due to measurement noise, additional motion or physiological artifacts like cardiac pulsation and respiration. Next, the volume timeseries were mapped into the standard CIFTI grayordinate space 97 The transformed correlation maps for each HCP150 subject were then aggregated using a one-way ttest at each grayordinate, as implemented in PALM. Thresholded maps representing the functional circuitry of the seed were obtained using permutation testing (500 permutations) with a generalized Pareto approximation of the tail of the null distribution 95 and threshold-free cluster enhancement 106 (TFCE), run separately for the cortical and sub-cortical areas, with a threshold of pFWE <.025, familywise error corrected (i.e., .05/2 to account for cortical and subcortical analyses). This procedure was repeated for each region in which at least one extreme deviation across individuals was observed (Figure 3b ). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint To quantify circuit-level overlap, we developed an approach that parallels traditional lesion network mapping methodology but which allows statistical inference on observed case-control differences in overlap scores at each region. Specifically, we thresholded each deviant-related FC map by applying TFCE to the grayordinate maps, as described above. We then classified an area in our 1032-region parcellation as showing significant FC with the seed if more than 50% of its grayordinates survived the TFCE threshold. We repeated our analysis using a mapping threshold of 75% to ensure that our findings were not driven by this specific choice (see Figure S13 -15). We mapped FC at the grayordinate level and thresholded the data in this way to leverage the superior statistical sensitivity of TFCE and to map the spatial architecture of the seed-related FC patterns more accurately. Our procedure resulted in a binary map representing the specific brain regions that comprise the functional circuitry of each seed (Figure 3c ). Then, for each individual, we took the union of the binary FC maps across that person's set of extrema, resulting in a single map identifying areas showing significant FC to any extreme deviation expressed by the person (Figure 3d ). Separate union maps were obtained for positive and negative deviations. The overlap of these union maps was then taken for each clinical group and the HCtest sample, representing, for each region, the proportion of individuals in that group for which significant deviant-related FC was identified. We refer to this image as a circuit-level overlap map (Figure 3e ).

Note that our approach focuses on FC between deviant and other areas as derived from a normative sample. It is possible that patterns of FC are altered in diagnosed individuals, and that the underlying network architecture differs from normative expectations. The net effect of such alterations would be to affect coupling between deviant and other areas, and thus our normative benchmark still offers an important reference point for understanding the distributed effects of regional deviations. Further investigation of how altered patterns of FC may moderate these relationships remains an important topic for future investigation.

We evaluated group differences in the circuit-level overlap maps of each clinical group relative to the HCtest group in two ways (see Figure S6 for a schematic overview). First, following the analysis of regional overlaps, we computed the difference in the case and control overlap maps (Δ overlap map, Figure 3e ) and evaluated the statistical significance of these differences with respect to an empirical null distribution generated by permuting the group labels of the individual-specific FC union maps 10,000 times, with a generalized Pareto Tail approximation 95 . Statistically significant differences in deviation FC overlap were identifying using a threshold of pFDR < 0.05, two-tailed ( Figure S6a-d) .

This group-based permutation test identifies regions where the overlap in deviant-related functional circuitry differs between cases and controls, but it does not preserve group differences in the total number of deviations. It therefore cannot distinguish whether any observed differences arise is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint from a preferential aggregation of deviations within specific circuits in one group relative to the other, or whether the group differences are driven by variations in total deviation burden. Note that differences in deviation burden should not be thought of as a confound in this context, since they are an intrinsic feature of the disease that will have real phenotypic consequences. Nonetheless, it is important to determine which findings might be driven by differences in deviation burden compared to a preferential accumulation of pathology within a specific circuit for a given disorder.

To disentangle these possibilities, we considered a second, spatial null model that preserves group differences in deviation burden. Specifically, we generated an ensemble of null cortical deviation maps for each individual in the test data by spatially rotating their empirical, unthresholded deviation maps ( Figure S6e ) using Hungarian spherical spin tests 107,108 ( Figure S6f ) and then thresholding these rotated maps in the same way as the observed data (i.e., Z> |2.6|; Figure S6g ). The

Hungarian method was used as it preserves the original values and spatial autocorrelation of the original map, which ensures that the surrogate data yields the same number of extrema as originally observed. This procedure could only be applied to the cortex, which is topologically equivalent to a sphere. The choice of an appropriate null model for subcortical areas is more complicated. While model-based procedures (e.g., 109 ) can generate surrogates with comparable spatial autocorrelation, they require parameter tuning, can show variable fits across individuals, and do not preserve the exact values of the original data, making thresholding challenging. We therefore randomly shuffled deviation values across subcortical areas before thresholding them. Note that this null model is more lenient than a spatially constrained test since the model preserves fewer features of the data. As we found no significant differences using this test, our results will not change under a more stringent, spatially constrained null model.

We then obtained individual-specific surrogate FC union maps using the same procedure described above (Figure S6h ), and calculated surrogate within-group overlap maps ( Figure S6i ) and between-group overlap difference maps ( Figure S6j ). This procedure was repeated 10,000 times to generate a null distribution of overlap difference maps for each disorder, again using the generalized Pareto tail approximation ( Figure S6k ). Statistically significant differences were identified using a threshold of pFDR < 0.05, two-tailed.

To summarize, group differences in circuit-level overlap were assessed with respect to two null models, one based on permutation of group labels and one based on spatial permutation of individual deviation maps. The group-based permutation test identifies regions showing differences in circuit-level overlap regardless of deviation burden. The spatial permutation test can be used to assess the degree to which such differences are driven by variations in deviation burden. More specifically, if a given brain region shows a significant difference for both tests, we have evidence to indicate that extreme deviations within the disorder preferentially aggregate within the functional circuitry of that region. If, on the other hand, a region shows a difference with the group-based permutation test but not the spatial permutation test, then the observed group differences are consistent with expectations . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint from randomly selecting of the same number of seeds in each group, indicating that the effects observed under group-based permutation can be attributed to the fact that one group has a higher deviation burden than the other. Note that this scenario still yields important information about the extent of circuit-level heterogeneity in the disorder, since we generally expect cases to have a higher deviation burden and any resulting circuit-level overlap will still have phenotypic consequences regardless of whether such overlaps are explained by deviation burden or not. The spatial permutation test simply offers additional insights into the potential mechanisms that may drive group differences in circuit-level overlap.

The above procedure offers a means for understanding heterogeneity at the level of neural circuits that show strong FC with a deviant region. However, it is still possible for some pairs of brain regions to be affiliated with the same extended functional network despite being weakly coupled themselves (Figure 1 right) . We therefore sought to characterize neural heterogeneity at the level of the broader functional networks within which a given deviant region may be embedded.

We assigned each cortical region to one of 7 canonical functional cortical networks using a well-validated network parcellation 54,58 and assigned each subcortical region to either the medial temporal lobe (amygdala and hippocampus), thalamus, or basal ganglia (nucleus accumbens, globus pallidus, putamen, caudate nucleus), as done previously 55 , resulting in a total of 10 distinct functional networks (Figure 4a-c) . The subcortical regions were assigned to coarse anatomical areas that were not aligned with the finely mapped cortical function networks because the correspondence between these subcortical nuclei, as parcellated here, and canonical cortical functional networks has not been extensively investigated. An alternative network assignment may influence network-level subcortical overlap values.

To characterize network-level heterogeneity, we examined the degree to which GMV deviations aggregated within each network. To this end, for each network, we estimated the proportion of individuals within each diagnostic group that showed at least one extreme deviation in a region assigned to that network, separately for positive and negative deviations (Figure 4d ). We then computed clinical-control differences in overlap proportions for each network (Figure 4e ).

As in the circuit-level analysis, these observed group differences in network-level overlap were evaluated with respect to two complementary null models. The first involved a group-based . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint randomization test in which a null distribution was generated by permuting group labels 10,000 times ( Figure S6a-d) . The second null model used the 10,000 spatially rotated maps generated in the circuitlevel analysis to obtain surrogate estimates of group differences in network-level overlap while preserving variation in deviation burden ( Figure S6e-g,l-o) . In both cases, the tail of the null distribution was approximated using a generalized Pareto distribution and we used a significance threshold of pFDR < 0.05, two-tailed. As in the circuit-level analysis, these two null models allowed us to distinguish preferential network involvement from the effects of total deviation burden. Note that comparisons in overlap values between networks are complicated by differences in network size. Our analysis therefore focuses primarily on comparisons between cases and controls within networks since the control data provide a critical normative benchmark against which cases can be compared. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

All code used to produce the figures in this study are freely available online and can be found at https://github.com/ashlea-segal/multiscale-heterogeneity-brain-abnormalities. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint U54 EB020403 to the ENIGMA Consortium from the BD2K Initiative, a cross-NIH partnership, and by the European College of Neuropsychopharmacology (ECNP) Network "ADHD Across the 

KA is a scientific advisor to and shareholder in BrainKey Inc., a medical image analysis software company. BF has received educational speaking fees from Medice GmbH. CFB is director and shareholder of SBGNeuro Ltd. OAA is a consultant to HealthLytix and received speaker's . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 10, 2022. ; https://doi.org/10.1101/2022.03.07.22271986 doi: medRxiv preprint honorarium from Lundbeck and Sunovion. MY has received philanthropic donations from the David

Gray matter abnormalities in Major Depressive Disorder: A meta-analysis of voxel based morphometry studies

Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis

Voxelwise Meta-Analysis of Gray Matter Abnormalities in Bipolar Disorder

Anatomical likelihood estimation meta-analysis of grey and white matter anomalies in autism spectrum disorders

Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies

Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects

Meta-analytic investigations of common and distinct grey matter alterations in youths and adults with obsessive-compulsive disorder

Cross-Disorder Analysis of Brain Structural Abnormalities in Six Major Psychiatric Disorders: A Secondary Analysis of Mega-and Meta-analytical Findings From the ENIGMA Consortium

Identification of a common neurobiological substrate for mental Illness

Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

An Empirical Comparison of Meta-and Mega-Analysis With Data From the ENIGMA Obsessive-Compulsive Disorder Working Group

Brain imaging of the cortex in ADHD: a coordinated analysis of largescale clinical and population-based samples

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium

Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group

Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD Working Group

Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study

One Quintillion Ways to Have PTSD Comorbidity: Recommendations for the Disordered DSM-5

The varied clinical presentations of major depressive disorder

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report

Individual differences v. the average patient: Mapping the heterogeneity in ADHD using normative models

Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models

Atypical Brain Asymmetry in Autism-A Candidate for Clinically Meaningful Stratification

Dissecting the Heterogeneous Cortical Anatomy of Autism Spectrum Disorder Using Normative Models

Individual deviations from normative models of brain structure in a large crosssectional schizophrenia cohort

Accommodating site variation in neuroimaging data using normative and hierarchical Bayesian models

Replicating extensive brain structural heterogeneity in individuals with schizophrenia and bipolar disorder

Understanding Heterogeneity in Clinical Cohorts Using Normative Models: Beyond Case-Control Studies

Diaschisis: Past, present, future

The connectomics of brain disorders

Die Lokalisation im Grosshirn und der Abbau der Funktion durch kortikale Herde

Network localization of neurological symptoms from focal brain lesions

Mapping Symptoms to Brain Networks with the Human Connectome

A human brain network derived from coma-causing brainstem lesions

Network localization of hemichorea-hemiballismus

Finding the imposter: Brain connectivity of lesions causing delusional misidentifications

Lesions causing freezing of gait localize to a cerebellar functional network

Lesion network localization of criminal behavior

Localizing parkinsonism based on focal brain lesions

Mapping holmes tremor circuit using the human brain connectome

Identifying therapeutic targets from spontaneous beneficial brain lesions

Network localization of heterogeneous neuroimaging findings

Network localization of cervical dystonia based on causal brain lesions

Neuroimaging in Parkinson's disease dementia: connecting the dots

A human memory circuit derived from brain lesions causing amnesia

Mapping migraine to a common brain network

Lesions causing hallucinations localize to one common brain network

A Human Depression Circuit Derived From Focal Brain Lesions

Mapping mania symptoms based on focal brain damage

Looking beyond the face area: Lesion network mapping of prosopagnosia

Cortical lesions causing loss of consciousness are anticorrelated with the dorsal brainstem

A Neural Circuit for Spirituality and Religiosity Derived From Patients With Brain Lesions

CAT-a computational anatomy toolbox for the analysis of structural MRI data

A fast diffeomorphic image registration algorithm

Local-Global Parcellation of the Human Cerebral Cortex from Intrinsic Functional Connectivity MRI

Topographic organization of the human subcortex unveiled with functional connectivity gradients

Hierarchical Bayesian Regression for Multi-site Normative Modeling of Neuroimaging Data

Visualising inter-subject variability in fMRI using thresholdweighted overlap maps

The organization of the human cerebral cortex estimated by intrinsic functional connectivity

Quantifying heterogeneity attributable to polythetic diagnostic criteria: Theoretical framework and empirical application

Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies

Cognitive control and the salience network: An investigation of error processing and effective connectivity

Salience network connectivity in the insula is associated with individual differences in interoceptive accuracy

Saliency, switching, attention and control: a network model of insula function

Salience network-based classification and prediction of symptom severity in children with autism

Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity

Aberrant resting-state brain activity in posttraumatic stress disorder: A meta-analysis and systematic review

Aberrant intra-salience network dynamic functional connectivity impairs large-scale network interactions in schizophrenia

Common and dissociable mechanisms of executive system dysfunction across psychiatricdisorders in youth

Identification of common neural circuit disruptions in cognitive control across psychiatric disorders

The p factor: One general psychopathology factor in the structure of psychiatric disorders?

Prefrontal cortex and depression

Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia

The prefrontal cortex and OCD

The Prefrontal Cortex: Categories, Concepts, and Cognitive Control

Cognitive Control in Depression: Toward Clinical Models Informed by Cognitive Neuroscience

Cognitive endophenotypes of bipolar disorder: A metaanalysis of neuropsychological deficits in euthymic patients and their first-degree relatives

The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex

The prefrontal cortex, pathological anxiety, and anxiety disorders

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: A systematic review and meta-analysis

Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer's disease

Network hubs in the human brain

The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies

Voxel-based morphometry -The methods

Motion artifacts in MRI: A complex problem with many partial solutions

MR artifacts: a review

Multi-site voxel-based morphometry -Not quite there yet

An analysis of transformations

Extensive brain structural heterogeneity in individuals with schizophrenia and bipolar disorder

Controlling the False Discovery Rate : A Practical and Powerful Approach to Multiple Testing Yoav Benjamini

Faster permutation inference in brain imaging

Permutation inference for the general linear model

The WU-Minn human connectome project: an overview

Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images

The minimal preprocessing pipelines for the Human Connectome Project

How to correct susceptibility distortions in spinecho echo-planar images: Application to diffusion tensor imaging

ICA-based artefact removal and accelerated fMRI acquisition for improved resting state network imaging

Evaluation of Denoising Strategies to Address Motion-Correlated Artifacts in Resting-State Functional Magnetic Resonance Imaging Data from the Human Connectome Project

Identifying and removing widespread signal deflections from fMRI data: Rethinking the global signal regression problem

Using temporal ICA to selectively remove global noise while preserving global signal in functional MRI data

Averaging Correlation Coefficients: Should Fisher's z Transformation Be Used?

Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

The Hungarian method for the assignment problem

Comparing spatial null models for brain maps

Generative modeling of brain maps with spatial autocorrelation

The autism brain imaging data exchange: Towards a large-scale evaluation of the intrinsic brain architecture in autism

Enhancing studies of the connectome in autism using the autism brain imaging data exchange II

Australian Schizophrenia Research Bank: A database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia

Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania

Functional connectivity of corticostriatal circuitry and psychosis-like experiences in the general community

Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects

Neural Processing of Emotional Musical and Nonmusical Stimuli in Depression

Neural processing of emotional musical and nonmusical stimuli in depression

Decoding moral judgments from neural representations of intentions

Moral judgments of intentional and accidental moral violations across Harm and Purity domains

Transdiagnostic variations in impulsivity and compulsivity in obsessivecompulsive disorder and gambling disorder correlate with effective connectivity in corticalstriatal-thalamic-cortical circuits

Resting state with closed eyes for patients with depression and healthy participants

fMRI Response of Parietal Brain Areas to Sad Facial Stimuli in Mild Depression

Brain structural correlates of obsessive-compulsive disorder with and without preceding stressful life events

Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders

Contrast Response Functions

Response dissociation in hierarchical cortical circuits: A unique feature of autism spectrum disorder

Suppressed activity of the rostral anterior cingulate cortex as a biomarker for depression remission